HEC83518
/ Sunshine Lake Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
May 02, 2026
the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
(clinicaltrials.gov)
- P1 | N=57 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Recruiting ➔ Completed
Trial completion • CNS Disorders • Insomnia • Sleep Disorder
May 02, 2026
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
(clinicaltrials.gov)
- P1 | N=74 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Recruiting ➔ Completed
Trial completion • CNS Disorders • Insomnia • Sleep Disorder
May 10, 2021
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
(clinicaltrials.gov)
- P1; N=70; Recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.; Trial completion date: Dec 2020 ➔ Jun 2021
Clinical • Trial completion date • CNS Disorders • Insomnia • Sleep Disorder
May 10, 2021
the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
(clinicaltrials.gov)
- P1; N=52; Recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • CNS Disorders • Insomnia • Sleep Disorder
December 14, 2020
the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
(clinicaltrials.gov)
- P1; N=52; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.
Clinical • New P1 trial • CNS Disorders • Insomnia • Sleep Disorder
1 to 5
Of
5
Go to page
1